Login

Dignitana 2020 Presentation - William Cronin, CEO Dignitana 00:00:00

Share On Facebook Share On Twitter

Dignitana 2020 Presentation

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CEO's Reflection on Sustainable Growth and Integration in Real Estate Development |Panote Sirivadhanabhakdi, Group CEO , Frasers Property.
00:10:00
Pan-Amyloid Removal Therapeutics by Attralus: A Novel Approach to Systemic Amyloidosis | Mark Timney, CHIEF EXECUTIVE OFFICER, ATTRALUS
00:10:00
Preparing for Shareholder Activism: Smart Risk Management Strategies
00:10:00
Raízen CEO Advocates Leadership Engagement for Corporate Transformation | Ricardo Mussa, CEO , Raízen SA.
00:10:00
Clarivate assists clients in finding, safeguarding, and promoting their inventions | JONATHAN GEAR, CEO, Clarivate PLC
00:10:00
A founder's inspiration to build|Brian Feinstein,Partner,Bessemer Venture Partners
00:10:00
Inside Taiwan's Cutting-Edge Semiconductor Mega Factories: A Journey of Innovation and Efficiency|C.C Wei,CEO,TSMC
00:10:00
AMSC CEO Pal Magnussen joined Steve Darling at the OTC in New York to discuss the company's strategic transition and recent developments.|Daniel McGahn, Chairman, President, and CEO of American Superconductor
00:10:00
Innovative 3D IP and Tensor Airborne Magnetics Revolutionizing Exploration Depth and Accuracy
00:10:00
Metso North Bay's Commitment to Safety, Lean Manufacturing, and Environmental Impact
00:10:00
Navigating the Future of Business Intelligence: Insights from OBASE CEO Dr. Bülent Dal | Dr. Bülent Dal, CEO, Obase Bilgisayar ve Danışmanlık Hizmetleri.
00:10:00
Female Founders are shaping China's Innovation Landscape with|Xu Ying,General Partner,Vertex Ventures

© 2026 Nehu